answersLogoWhite

0

As of my last update in October 2023, specific net worth figures for individuals like Gordon Binder, the former CEO of Amgen, may not be publicly available or may vary over time. However, it is known that he has had a significant impact on the biotechnology industry and has likely accumulated considerable wealth through his career and investments. For the most accurate and current information, it would be best to consult financial news sources or databases.

User Avatar

AnswerBot

1mo ago

What else can I help you with?

Related Questions

When was Gordon Binder born?

Gordon Binder was born in 1935.


When was Amgen created?

Amgen was created in 1980.


What is the population of Amgen?

The population of Amgen is 17,400.


What is the ticker symbol for Amgen?

The ticker symbol for Amgen is AMGN and it is traded on the Nasdaq.


What is the symbol for Amgen Inc in NASDAQ?

The symbol for Amgen Inc. in NASDAQ is: AMGN.


In what year did Amgen Inc - AMGN - have its IPO?

Amgen Inc. (AMGN) had its IPO in 1983.


Who was the lead underwriter on the Amgen IPO?

The company name Amgen comes from the original company name, which is Applied Molecular Genetics. Goldman Sachs was the lead underwriter on the Amgen IPO.


What is the market cap for Amgen Inc AMGN?

As of July 2014, the market cap for Amgen Inc. (AMGN) is $92,553,466,684.48.


What does the company name Amgen stand for?

The company name Amgen comes from the original company name of Applied Molecular GENetics


How much joseph Gordon- levitt worth?

Joseph Gordon-Levitt Is worth, net total: $25.000.000.


What does Amgen typically produce?

Amgen is a company that produces medicines for biological illnesses. Many of their biologic therapies are made through using genetic engineering of living cells.


Who is Bruce Wallace amgen?

Bruce Wallace is a prominent figure at Amgen, serving as the company's Senior Vice President of Operations. He has extensive experience in the biopharmaceutical industry, focusing on manufacturing, supply chain management, and operational excellence. Under his leadership, Amgen has worked to enhance its production capabilities and ensure the delivery of high-quality therapeutics. Wallace's contributions have been integral to Amgen's mission of advancing science and improving health outcomes.